ROBERT A GOODNOW JR
PH.D GLOBAL MEDICINAL CHEMISTRY OUTSOURCING 
HOFFMANN-LA ROCHE INC.

Biography
Rob Goodnow earned his BS in chemistry at Georgetown University, and his Ph.D. in natural products chemistry at Columbia University.  After working as post-doctoral fellow at Princeton University on solid phase oligosaccharide synthesis, Rob joined Hoffmann-La Roche at Nutley in 1993 Nutley in the antisense research group.  Over the years, Rob has been engaged in multiple medicinal chemistry research projects in several therapeutic areas; he has also been an active proponent of high throughput chemistry methods. Rob has managed a long series of outsourced research collaborations for Roche since 1999 on a local and global level.  In 2009, he has been appointed to the role of Global Head of Medicinal Chemistry Outsourcing at Roche.  Rob also active in Roche’s research efforts for siRNA Therapeutics.

Chris Waller, Pfizer Inc
Senior Director of Precompetitive Collaborations in Worldwide Technology

Chris L. Waller, Ph.D. is the Senior Director of Precompetitive Collaborations in Worldwide Technology at Pfizer, Inc., where his interest is in the development of collaborations between pharmaceutical, biotechnology, technology, academic, and government organizations to develop and promote the use of standards, identify partnerships, and transfer technology in order to drive greater process efficiency and lower costs. Waller has a Doctorate in Medicinal Chemistry and Natural Products from the University of North Carolina-Chapel Hill and a Bachelors of Science in Pre-medical Studies from Davidson College.

In his current role, Waller is spearheading a new initiative within Pfizer that consists of three primary elements: (1) the definition and promotion of industry standards (e.g., data models, APIs, processes, etc.) across the Research and Development and Medical continuum through participation on various cross-pharmaceutical company entities (e.g., Waller is a Senior Core Member of the Pistoia Alliance, Inc.); (2) proactive pursuit of pre/non-competitive collaborative application or technology development opportunities (e.g., industry partnerships focused on the development of commodity applications or services); and (3) identification and cultivation of opportunities to generate revenue by monetizing Pfizer’s portfolio of products and services (e.g., divestment and/or licensing of Pfizer-developed applications).

He was previously Worldwide Head of Chemistry Informatics at Pfizer where he was responsible for the strategic direction of the IT portfolio of products and services in support of enterprise chemical and biological data access and analysis as well as medicinal chemistry compound design and synthesis. Prior to joining Pfizer, Waller held various positions at Eli Lilly and Company (Sphinx Laboratories), OSI Pharmaceuticals, Inc. and the U.S. Environmental Protection Agency.

Mats Sundgren, PhD, MSc. Principal Scientist
Global Clinical Development, AstraZeneca R&D

Mats Sundgren, PhD, MSc. Mats is a Principal Scientist in Global Clinical Development, AstraZeneca R&D, and have more than 23 years of experience in the pharmaceutical industry (Discovery, Development, Marketing, and Patents). His PhD research was focused on Managing Innovation in pharmaceutical R&D.

He is currently working within the area of R&D strategy focusing on implementing strategies for bridging Health Information Technology with clinical trials. He is a member of the corporate HIT (Health Information Technology) expert team, is a member of the Scientific Advisory Board for GE Health Division. He is representing AZ in the IMI (Innovative Medicine Initiative) Knowledge Management project group and is one of the coordinators for IMI 2009 research calls. Mats is also a Senior Research fellow associate with Chalmers University of Technology & IT University of Gothenburg, Sweden, in areas of Innovation Management, Medical Informatics and eHealth, and a member of evaluation board for VINNOVA (The Swedish Governmental Agency for Innovation Systems). Mats is a senior research fellow at the department of organization renewal and entrepreneurship, Chalmers University of Technology and is affiliated to the IT University of Gothenburg, and he is a frequently invited key note speaker in conferences during 2008-2009 (e.g. DIA 2008, eClinical Trials 2008-2009, The Evolution of Data Management in Pharma 2008, Bio IT Conference 2009, Breakthrough in Innovation, 2009).